KH6.F - NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Truist SecuritiesInitiation

NAMS - Prevailing in the Graveyard: Why This CETP Won’t Bury You. Initiating with a Buy and $57 PT.

公司
KH6.F
日期
2026-03-18
分析师
Ms. Srikripa Devarakonda, PHD
页数
56
需要登录
请登录后购买研报或生成音频内容。